Autoimmune conditions and NADPH oxidase defects

Details for Australian Patent Application No. 2007224438 (hide)

Owner Biovitrum AB (publ)

Inventors Linschoten, Marcel; Alekseevich, Tomalchev Andrey; Bergman, Anders; Olofsson, Peter

Agent Shelston IP

Pub. Number AU-B-2007224438

PCT Pub. Number WO2007/104790

Priority 60/782,381 15.03.06 US

Filing date 15 March 2007

Wipo publication date 20 September 2007

Acceptance publication date 26 July 2012

International Classifications

A61K 31/045 - Hydroxy compounds, e.g. alcohols

A61P 37/06 Drugs for immunological or allergic disorders

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/104790 Priority application(s): WO2007/104790

26 July 2012 Application Accepted

  Published as AU-B-2007224438

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224439

2007224431-1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mGluR2-recept0r modulators